X0708 D LIVE 0001574565 Evogene Ltd. 13 GAD FEINSTEIN STREET PARK REHOVOT REHOVOT L3 ISRAEL 7638517 97289311900 ISRAEL None None Corporation true Ofer Haviv c/o Evogene Ltd. 13 Gad Feinstein Street, Park Rehovot Rehovot L3 ISRAEL 7638517 Executive Officer Director President and Chief Executive Officer and Director Yaron Eldad c/o Evogene Ltd. 13 Gad Feinstein Street, Park Rehovot Rehovot L3 ISRAEL 7638517 Executive Officer Chief Financial Officer Gabi Tarcic c/o Evogene Ltd. 13 Gad Feinstein Street, Park Rehovot Rehovot L3 ISRAEL 7638517 Executive Officer Vice President Product Ilia Zhidkov c/o Evogene Ltd. 13 Gad Feinstein Street, Park Rehovot Rehovot L3 ISRAEL 7638517 Executive Officer Vice President Computational Platform Nir Nimrodi c/o Evogene Ltd. 13 Gad Feinstein Street, Park Rehovot Rehovot L3 ISRAEL 7638517 Director Chairperson of the Board Sarit Firon c/o Evogene Ltd. 13 Gad Feinstein Street, Park Rehovot Rehovot L3 ISRAEL 7638517 Director Dan Falk c/o Evogene Ltd. 13 Gad Feinstein Street, Park Rehovot Rehovot L3 ISRAEL 7638517 Director Adrian Percy c/o Evogene Ltd. 13 Gad Feinstein Street, Park Rehovot Rehovot L3 ISRAEL 7638517 Director Leon Yehuda Recanati c/o Evogene Ltd. 13 Gad Feinstein Street, Park Rehovot Rehovot L3 ISRAEL 7638517 Director Pharmaceuticals Decline to Disclose 06b false 2026-02-11 false true true false 0 A.G.P./Alliance Global Partners 000008361 None None 590 Madison Avenue 28th Floor New York NY NEW YORK 10022 NY NEW YORK false 3384616 3384616 0 Gross proceeds reflect the cash exercise of 3,384,616 existing warrants at an exercise price of $1.00 per share in a warrant inducement transaction. As part of the inducement, the Company issued new warrants to purchase up to 5,076,924 shares. Gross proce false 1 236923 0 0 false Evogene Ltd. /s/ Yaron Eldad Yaron Eldad Chief Financial Officer 2026-02-19